WILMINGTON, Del., Feb. 21 /PRNewswire-FirstCall/ -- AstraZeneca
believes this lawsuit is legally and factually unfounded and we intend to
appeal to the Alabama Supreme Court, if the trial court does not reject the
jury's verdict. The case was based on the misleading premise that the
Alabama State Medicaid Agency did not understand the basics on how drug
prices are established and reported.
We believe numerous errors occurred during the proceedings and that the
verdict should not be upheld.
For example, the Court ruled that important information on the workings
of the Alabama pharmacy system be withheld throughout the trial. The Court
also permitted evidence of earlier, unrelated settlements and proceedings
in clear violation of the rules of evidence. These and other reversible
errors were compounded by negative public comments by the trial lawyers and
state leaders prior to the jury selection process.
AstraZeneca has fully complied with the law, government guidelines and
contracts that govern Medicaid pricing. We currently provide medicines to
Medicaid programs at the lowest price that we offer to our best business
clients, as federal law requires.
AstraZeneca and the State Medicaid program share a common goal of
helping people access the medicines they need.
To help patients who have difficulty affording their medicines, we
offer patient assistance programs side by side with our medicines. In the
last two years alone, AstraZeneca helped more than 28,800 Alabama patients
receive more than $25.5 million in savings through its prescription savings
programs.
SOURCE AstraZeneca
 back to top
Related links:
http://www.astrazeneca-us.com/
http://www.prnewswire.com/comp/985887.html/
CONTACT:
Tony Jewell, +1-302-885-4594,
Tony.Jewell@AstraZeneca.com, or Laura Woodin, +1-302-885-1087,
Laura.Woodin@AstraZeneca.com, both of AstraZeneca
|
